In vitro characteristics of nicotine microspheres for transnasal delivery

International Journal of Pharmaceutics

Volumn 129, Issue 1-2, 1996, Pages 175-183

  Cornaz, A L ^a   De Ascentis, A ^b   Colombo, P ^b   Buri, P ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Dextran microspheres; In vitro characterization; Nicotine; Transnasal delivery

Indexed keywords

DEXTRAN; MICROSPHERE; NICOTINE; NICOTINE TARTRATE; SEPHADEX;

ARTICLE; DIFFUSION CHAMBER; DRUG DELIVERY SYSTEM; DRUG RELEASE; NOSE MUCOSA; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 0030005177     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04289-X     Document Type: Article

References (19)

1. Björk, E. and Edman, P., Characterization of degradable starch microspheres as a nasal delivery system for drugs. Int. J. Pharm., 62 (1990) 187-192.
2. Edman, P., Björk, E. and Ryden, L., Microspheres as a nasal delivery system for peptide drugs. J. Controlled Release, 21 (1992) 165-172.
3. Illum, L., Jörgensen, H., Bisgaard, H., Krogsgaard, O. and Rossing, N., Bioadhesive microspheres as a potential nasasl drug delivery system. Int. J. Pharm., 39 (1987) 189-199.
4. Jarvis, M.J., Hajek, P., Russel, M.A.H., West, R.J. and Feyerabend, C., Nasal nicotine solution as an aid to cigarette withdrawal: a pilot clinical trial. Br. J. Addict., 82 (1987) 983-988.
5. Jarvis, M.J. and Henningfield, J.E., Pharmacologic treatment of tobacco dependance. Pharmacol. Biochem. Behav., 30 (1988) 279-294.
6. Nogami, H., Nagai, T., Fukuoka, E. and Sonobe, T., Disintegration of the aspirin tablets containing potato starch and microcrystalline cellulose in various concentrations. Chem. Pharm. Bull., 17 (1969) 1450-1455.
7. Perkins, K.A., Grobe, J.E., Stiller, R.L., Fonte, C. and Goettler, J.E., Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior. Clin. Pharmacol. Ther., 52 (6) (1992) 627-634.
8. Pomerleau, O.F., Flessland, K.A., Pomerleau, C.S. and Hariharan, M., Controlled dosing of nicotine via an intranasal nicotine aerosol delivery device (INADD). Psychopharmacology, 108 (1992) 519-526.
9. Provasi, D., De Ascentis, A. and Colombo, P., Powder delivery from devices for nasal application. The 12th Pharmaceutical Technology Conference, Elsinore, Denmark, 3 (1993a) 98-111.
10. Provasi, D., De Ascentis, A., Minutello, A., Colombo, P. and Catellani, P.L., Nasal delivery progesterone powder formulations comparison with oral administration. Boll. Chim. Farmac., 132(10) (1993b) 402-404.
11. Provasi, D., De Ascentis, A., Minutello, A., Colombo, P. and Catellani, P.L., Nasal powders of progesterone: manufacturing and bioavailability. Eur. J. Pharm. Biopharm., 40(4) (1994) 223-227.
12. Russel, M.A.H., Jarvis, M.J. and Feyerabend, C., A new age for snuff? Lancet, i (1980) 474-475.
13. Russel, M.A.H., Jarvis, M.J., Feyerabend, C. and Fernö, O., Nasal nicotine solution: a potential aid to giving up smoking? Br. Med. J., 286 (1983) 683-684.
14. Ryden, L. and Edman, P., Effect of polymers and microspheres on the nasal absorption of insulin in rats. Int. J. Pharm., 83 (1992) 1-10.
15. Schneider, N.G., Nicotine nasal spray. Health Values, 18(3) (1994) 10-14.
16. Sutherland, G., Russel, M.A.H., Stapleton, J.A., Feyerabend, C. and Fernö, O., Nasal nicotine spray: a rapid nicotine delivery system. Psychopharmacology, 108 (1992) 512-518.
17. Svensson, C.K., Clinical pharmacokinetics of nicotine. Clin. Pharmacokinet., 12 (1987) 30-40.
18. Vidgren, M., Kärkkäinen, A., Karjalainen, P., Paronen, P. and Nuutinen, J., Effect of powder inhaler design on drug deposition in the respiratory tract. Int. J. Pharm., 42 (1988) 211-216.
19. West, R.J., Jarvis, M.J., Russel, M.A.H. and Feyerabend, C., Plasma nicotine concentrations from repeated doses of nasal nicotine solution. Br. J. Addict., 79 (1984) 443-445.